Fed. Circ. Throws Out $4.7M Verdict In DNA Patent Suit
The Federal Circuit reversed a Delaware federal jury's verdict from 2021 that found biotechnology company Qiagen Sciences LLC owed $4.7 million for infringing genetic testing patents, saying the jury's findings weren't...To view the full article, register now.
Already a subscriber? Click here to view full article